The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.
about
The use and misuse of positron emission tomography in lung cancer evaluationClinical application of positron emission tomography in designing radiation fields in non-small cell lung cancer patients.Systematic Endobronchial Ultrasound-guided Mediastinal Staging Versus Positron Emission Tomography for Comprehensive Mediastinal Staging in NSCLC Before Radical Radiotherapy of Non-small Cell Lung Cancer: A Pilot Study18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.Intratumoural chemotherapy of lung cancer for diagnosis and treatment of draining lymph node metastasis.Sampling versus systematic full lymphatic dissection in surgical treatment of non-small cell lung cancerRelationship Between the Size of Metastatic Lymph Nodes and Positron Emission Tomographic/Computer Tomographic Findings in Patients with Esophageal Squamous Cell Carcinoma.Clinicopathological Characteristics of Lung Adenocarcinoma with Unexpected Lymph Node MetastasisPositron emission tomography with CT in the evaluation of non-small cell lung cancer in populations with a high prevalence of tuberculosis.Influence of region-of-interest determination on measurement of signal-to-noise ratio in liver on PET images.Advantages of FDG-PET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer.Diffusion-weighted imaging can correctly identify false-positive lymph nodes on positron emission tomography in non-small cell lung cancer.Positron-emission tomography for lung cancer in a tuberculosis-endemic region.[Role of PET/CT in primitive non-small cell bronchopulmonary cancer].
P2860
Q27021838-AB6B658C-2ED9-44C0-A62C-CF0FE2D4541CQ36246702-12B70EF0-FD41-4767-A152-2A6E09EAF696Q36653508-1C78479E-B1D0-4044-BE70-2CCF30FBA79EQ37016566-FCBAE791-B21A-48A7-94AD-ACA93C713CA8Q37757142-ED9F0EE6-B5D1-44A4-BCA2-E94B251A8D1EQ38493169-97EF7BD1-422E-4F16-A4F1-E8C563FA95F0Q40589439-8CAEE588-91BB-4EC6-AC46-CDCFC89BC670Q41505344-D11994E8-962C-4346-9010-94F4A9A8B3ACQ47653945-B365FE20-DEC5-4228-829B-3E4A6FC64335Q50067410-8DECD6FE-0D23-416D-B9DE-0A5C5E058388Q51071702-5028B003-FE36-4776-843B-C458C33DFC25Q52986979-DC0A46CB-E196-4FC5-858E-851745E70FA7Q53344718-9F9C835D-EDD4-43F8-8197-BC88A36B8D90Q54102386-D7DD63C7-DD21-4A04-94AA-49DB6FB9017E
P2860
The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The size of metastatic foci an ...... in patients with lung cancer.
@ast
The size of metastatic foci an ...... in patients with lung cancer.
@en
type
label
The size of metastatic foci an ...... in patients with lung cancer.
@ast
The size of metastatic foci an ...... in patients with lung cancer.
@en
prefLabel
The size of metastatic foci an ...... in patients with lung cancer.
@ast
The size of metastatic foci an ...... in patients with lung cancer.
@en
P2093
P1476
The size of metastatic foci an ...... y in patients with lung cancer
@en
P2093
Hiroaki Nomori
Keiichi Suemasu
Kenichi Watanabe
Kimiichi Uno
Tsuguo Naruke
P304
P356
10.1016/J.JTCVS.2003.08.010
P407
P577
2004-04-01T00:00:00Z